1026 - 1050 of 6515 Results
Title
Year
-
OPENTitle: Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS ConsortiumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 106End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12033Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7202045Citation Count: 159
-
OPENTitle: Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortiumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 79End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2019.05.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6949373Citation Count: 90
-
OPENTitle: Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 3Start Page: 417End Page: 430Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12198Best OA location URL: https://doi.org/10.1002/alz.12198Citation Count: 71
-
OPENTitle: Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohortJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 60End Page: 70Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12046Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7192555Citation Count: 45
-
OPENTitle: Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier statusJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 12Start Page: 1663End Page: 1673Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12161Best OA location URL: https://doi.org/10.1002/alz.12161Citation Count: 91
-
OPENTitle: Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 7Start Page: 965End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.12083Best OA location URL: https://doi.org/10.1002/alz.12083Citation Count: 67
-
OPENTitle: Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learningJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.047358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.047358Citation Count: 0
-
OPENTitle: Creating a patient‐centered guide to navigating cognitive change in Parkinson’s diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.041115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.041115Citation Count: 0
-
OPENTitle: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpointJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 11End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.01.012Citation Count: 51
-
OPENTitle: Genetic screening of a large series of North American sporadic and familial frontotemporal dementia casesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 118End Page: 130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7199807Citation Count: 76
-
OPENTitle: Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 5Start Page: 831End Page: 846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12240Best OA location URL: https://doi.org/10.1002/alz.12240Citation Count: 22
-
OPENTitle: New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 131End Page: 143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2019.06.4956Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6949386Citation Count: 64
-
OPENTitle: Non‐coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in womenJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 2Start Page: 215End Page: 225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12181Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7920533Citation Count: 36
-
OPENTitle: Cerebrovascular medin is associated with Alzheimer's disease and vascular dementiaJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 12Issue #: 1Start Page: e12072End Page: e12072Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12072Best OA location URL: https://doi.org/10.1002/dad2.12072Citation Count: 28
-
OPENTitle: Cognition in multiple system atrophy: a single‐center cohort studyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 2Start Page: 219End Page: 228Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.50987Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.50987Citation Count: 43
-
OPENTitle: Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes NeurotoxicJournal Name: Angewandte ChemiePublisher: WileyVol: 133Issue #: 17Start Page: 9299End Page: 9330Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ange.202000451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202000451Citation Count: 13
-
OPENTitle: Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 91End Page: 105Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12001Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12001Citation Count: 42
-
OPENTitle: Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.022Best OA location URL: http://www.prd-journal.com/article/S1353802019300227/pdfCitation Count: 99
-
OPENTitle: Amygdala sign, a FDG-PET signature of dementia with Lewy BodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 300End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6739145Citation Count: 12
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 17
-
OPENTitle: Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 3End Page: 12Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.040Best OA location URL: http://www.prd-journal.com/article/S1353802019302615/pdfCitation Count: 42
-
OPENTitle: Temporal discrimination threshold and blink reflex recovery cycle in cervical dystonia – two sides of the same coin?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 4End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.028Citation Count: 7
-
OPENTitle: Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.021Best OA location URL: http://www.prd-journal.com/article/S1353802019300215/pdfCitation Count: 54
-
OPENTitle: Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.005Best OA location URL: https://doi.org/10.1016/j.parkreldis.2018.09.005Citation Count: 28
-
OPENTitle: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyJournal Name: Schizophrenia ResearchPublisher: Elsevier BVVol: 214Issue #:Start Page: 3End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038Citation Count: 86